Go to MPEP - Table of Contents
2400 Biotechnology
2400 Biotechnology
2401 Introduction
2402 The Deposit Rules
2403 Deposit of Biological Material
2403.01 Material Capable of Self- Replication
2403.02 Plant Material
2404 Need or Opportunity to Make a Deposit
2404.01 Biological Material That Is Known and Readily Available to the Public
2404.02 Biological Material That Can Be Made or Isolated Without Undue Experimentation
2404.03 Reference to a Deposit in the Specification
2405 Acceptable Depository
2406 Time of Making an Original Deposit
2406.01 Description in Application Specification
2406.02 Deposit After Filing Date - Corroboration
2406.03 Possible Loss of U.S. Filing Date in Other Countries
2407 Replacement or Supplement of Deposit
2407.01 In a Pending Application
2407.02 After a Patent Has Issued
2407.03 Failure to Replace
2407.04 Treatment of Replacement
2407.05 Exemption From Replacement
2407.06 Replacement May Not Be Recognized
2408 Term of Deposit
2409 Viability of Deposit
2410 Furnishing of Samples
2410.01 Conditions of Deposit
2410.02 Certification of Statement of Availability of Deposit
2411 Examination Procedures
2411.01 Rejections Based on Deposit Issue
2411.02 Replies to Rejections Based on Deposit Issue
2411.03 Application in Condition for Allowance Except for Deposit
2411.04 After a Patent Has Been Granted
2411.05 Content of Application with Respect to Deposited Material
2420 The Requirements for Patent Applications Containing Nucleotide Sequence and/or Amino Acid Sequence Disclosures - the Sequence Rules
2421 Overview of the Sequence Rules
2421.01 Applications Affected
2421.02 Summary of the Requirements of the Sequence Rules
2421.03 Notification of a Failure to Comply
2421.04 Future Changes to the Sequence Rules
2422 Nucleotide and/or Amino Acid Sequence Disclosures in Patent Applications
2422.01 Definitions of Nucleotide and/or Amino Acids for Purpose of Sequence Rules
2422.02 The Requirement for Exclusive Conformance; Sequences Presented in Drawing Figures
2422.03 The Requirements for a Sequence Listing and Sequence Identifiers; Sequences Embed- ded in Application Text; Vari- ants of a Presented Sequence
2422.04 The Requirement for a Computer Readable Copy of the Official Copy of the Sequence Listing
2422.05 Reference to Previously Filed Identical Computer Readable Form; Continuing or Derivative Applications; Request for Transfer of Computer Readable Form
2422.06 Requirement for Statement Regarding Content of Official and Computer Readable Copies of Sequence Listing
2422.07 Requirements for Compliance, Statements Regarding New Matter, and Sanctions for Failure to Comply
2422.08 Presumptions Regarding Compliance
2422.09 Box Sequence; Hand Delivery of Sequence Listings and Computer Readable Forms
2423 Symbols and Format To Be Used for Nucleotide and/or Amino Acid Sequence Data
2423.01 Format and Symbols To Be Used in Sequence Listings
2423.02 Depiction of Coding Regions
2423.03 Presentation and Enumeration of Sequences
2424 Requirements for Nucleotide and/or Amino Acid Sequences as Part of the Application Papers
2424.01 Informational Requirements for the Sequence Listing
2424.02 Sequence Listing Numeric Identifiers
2424.03 Additional Miscellaneous Requirements
2425 Form and Format for Nucleotide and/or Amino Acid Sequence Submissions in Computer Readable Form
2426 Amendments to or Replacement of Sequence Listing and Computer Readable Copy Thereof
2427 Form Paragraphs and Notice to Comply
2427.01 Form Paragraphs
2427.02 Notice To Comply
2428 Sample Statements
2429 Helpful Hints for Compliance
2430 PatentIn Information; Utilities Programs; Training
2431 Sample Sequence Listing
2434 Examination of Patent Applications Claiming Large Numbers of Nucleotide Sequences
2435 Publishing of Patents and Patent Application Publications with Lengthy Sequence Listings
2400 Biotechnology
Go to MPEP - Table of Contents